| GA20162-5mg |
|
65807-03-6 |
|
0 |
C55H76N18O14 |
|
|
|
| GA20162-1mg |
|
65807-03-6 |
|
0 |
C55H76N18O14 |
|
|
|
| GA20161-5mg |
|
102992-39-2 |
|
0 |
C64H82N18O13 |
|
|
|
| GA20161-1mg |
|
102992-39-2 |
|
0 |
C64H82N18O13 |
|
|
|
| GA20160-5mg |
|
1926163-39-4 |
(D-Ser⁴,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH
|
0 |
C59H84N18O14 |
|
|
|
| GA20160-1mg |
|
1926163-39-4 |
(D-Ser⁴,D-Ser(tBu)⁶,Azagly¹⁰)-LHRH
|
0 |
C59H84N18O14 |
|
|
|
| GA20159-5mg |
|
103065-82-3 |
|
0 |
C55H75N17O13 |
|
|
|
| GA20159-1mg |
|
103065-82-3 |
|
0 |
C55H75N17O13 |
|
|
|
| GA20158-1mg |
|
18067-65-7 |
(D-Ser¹)-ACTH (1-24) (human, bovine, rat)
|
0 |
C136H210N40O31S |
|
|
|
| GA20158-005mg |
|
18067-65-7 |
(D-Ser¹)-ACTH (1-24) (human, bovine, rat)
|
0 |
C136H210N40O31S |
|
|
|
| GA20157-5mg |
|
1926163-38-3 |
(D-Ser(tBu)⁶,D-Leu⁷,Azagly¹⁰)-LHRH
|
0 |
C59H84N18O14 |
|
|
|
| GA20157-1mg |
|
1926163-38-3 |
(D-Ser(tBu)⁶,D-Leu⁷,Azagly¹⁰)-LHRH
|
0 |
C59H84N18O14 |
|
|
|
| GA20156-25mg |
|
65807-02-5 |
(D-Ser(tBu)⁶,Azagly¹⁰)-LHRH (free base)
|
0 |
C59H84N18O14 |
|
|
|
| GA20156-5mg |
|
65807-02-5 |
(D-Ser(tBu)⁶,Azagly¹⁰)-LHRH (free base)
|
0 |
C59H84N18O14 |
|
|
|
| GA20155-1mg |
|
586962-44-9 |
(D-Pro⁷)-Angiotensin I/II (1-7)
|
0 |
C41H62N12O11 |
|
|
|
| GA20154-25mg |
|
86917-57-9 |
(D-Pro⁴,D-Trp⁷·⁹·¹⁰)-Substance P (4-11)
|
0 |
C62H74N14O10S |
|
|
|
| GA20154-5mg |
|
86917-57-9 |
(D-Pro⁴,D-Trp⁷·⁹·¹⁰)-Substance P (4-11)
|
0 |
C62H74N14O10S |
|
|
|
| GA20153-5mg |
|
109212-72-8 |
(D-Pro²,D-Trp⁶·⁸,Nle¹⁰)-Neurokinin B
|
0 |
C67H87N15O14 |
|
|
|
| GA20153-1mg |
|
109212-72-8 |
(D-Pro²,D-Trp⁶·⁸,Nle¹⁰)-Neurokinin B
|
0 |
C67H87N15O14 |
|
|
|
| GA20152-100mg |
|
117027-34-6 |
(D-Pro¹⁹⁴)-IL-1β (193-195) (human)
|
0 |
C15H28N4O5 |
|
|
|
